University Clinic of Respiratory and Allergic Diseases
Golnik, 4204, Slovenia
NCT Number: NCT01178918
This is a prospective observational study with recruitment of healthy volunteers from consecutive recipients of H1N1 influenza vaccine at the University Clinic of Respiratory and Allergic Diseases, Golnik, Slovenia.
The purpose of this study is to evaluate certain safety aspects of adjuvanted influenza H1N1 vaccines.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Golnik, 4204, Slovenia
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: At 3 weeks after vaccination
Time frame: At 11 weeks after vaccination.
The University Clinic of Pulmonary and Allergic Diseases Golnik
Other
Enhanced Non-Specific T Lymphocytes Response to Influenza A (H1N1) AS03-Adjuvanted Vaccine
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.